Kyntra Bio, Inc. (KYNB)
8.22
+0.72
(+9.60%)
USD |
NASDAQ |
Feb 06, 16:00
8.30
+0.08
(+0.97%)
After-Hours: 20:00
Kyntra Bio SG&A Expense (TTM) : 28.80M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 63.52M |
| Perspective Therapeutics, Inc. | 31.53M |
| Harrow, Inc. | 144.39M |
| Skye Bioscience, Inc. | 16.93M |
| Theravance Biopharma, Inc. | 75.94M |